BC tissues; adjacent non-tumor tissues; serum
MDA-MB-231; MCF-7; HEK-293T
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); EMT (promotes); ceRNA regulation (promotes)
Microarray; RT-qPCR; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
Serum hsa_circ_0001756 is elevated in BC patients and shows diagnostic value (ROC AUC), and is correlated with tumor size, age, lymph node metastases/metastasis state, and TNM stage; combination with CEA and CA15-3 improves diagnostic accuracy.
hsa_circ_0001756 (CircHIPK2) is up-regulated in breast cancer tissues/cells and promotes tumor growth, proliferation, migration, invasion and EMT. It mainly localizes to the cytoplasm and acts as a ceRNA sponge for miR-584-5p to upregulate TRAF6. Serum hsa_circ_0001756 is elevated in BC and has diagnostic value, especially combined with CEA and CA15-3.
0.8556
Hsa_circ_0001756, a novel biomarker, promotes breast cancer progression via miR-584-5p/TRAF6 signaling axis.
combined biological and clinical study